Proteomic profiling of cancer of the gingivo-buccal complex: Identification of new differentially expressed markers

Proteomics - Clinical Applications

Volumn 3, Issue 12, 2009, Pages 1451-1462

  Govekar, Rukmini B ^a   D'Cruz, Anil K ^a   Pathak, K Alok ^a   Agarwal, Jaiprakash ^a   Dinshaw, Ketayun A ^a   Chinoy, Roshan F ^a   Gadewal, Nikhil ^a   Kannan, Sadhana ^a   Sirdeshmukh, Ravi ^b   Sundaram, Curam S ^b   Malgundkar, Siddhi A ^a   Kane, Shubhada V ^a   Zingde, Surekha M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

2 DE; Gingivo buccal complex; MS; Oral cancer

Indexed keywords

ALPHA ENOLASE; APOLIPOPROTEIN A1; CATHEPSIN D; LACTATE DEHYDROGENASE ISOENZYME 1; PROHIBITIN; STRATIFIN; TROPOMYOSIN; TUMOR MARKER; TUMOR PROTEIN TRANSLATIONALLY CONTROLLED 1; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CLUSTER ANALYSIS; CONTROLLED STUDY; GINGIVOBUCCAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; MOUTH CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

NICOTIANA TABACUM;

EID: 77951060643     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900023     Document Type: Article

References (50)

1. Parkin, D. M., Pisani, P., Ferlay, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer 1993, 54, 594-606.
2. Dinshaw, K., Ganesh, B., Annual Report-2001, Hospital Based Cancer Registry, Tata Memorial Hospital, 2005.
3. Warnakulasuriya, S. in: Vogelstein, B., kinzler, K. W. Genetics Basis of Human Cancer, Chapter 51, McGraw-Hill, London 2002, pp 773-784.
4. Nagpal, J. K., Das, B. R., Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol. 2003, 39, 213-221.
5. Patel, V., Leethanakul, C., Gutkind, J. S., New approaches to the understanding of the molecular basis of oral cancer. Crit. Rev. Oral. Biol. Med. 2001, 12, 55-63.
6. Schliephake, H., Prognostic relevance of molecular markers of oral cancer - a review. Int. J. Oral Maxillofac. Surg. 2003, 32, 233-245.
7. Hunter, K. D., Parkinson, E. K., Harrison, P. R., Profiling early head and neck cancer. Nat. Rev. Cancer 2005, 5, 127-135.
8. Molinolo, A. A., Amornphimoltham, P., Squarize, C. H., Castilho, R. M. et al., Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol. 2009, 45, 324-334.
9. Chen, J., He, Q. Y., Yuen, A. P., Chiu, J. F., Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 2004, 4, 2465-2475.
10. Lo, W. Y., Tsai, M. H., Tsai, Y., Hua, C. H. et al., Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin. Chim. Acta 2007, 376, 101-107.
11. Wang, Z., Jiang, L., Huang, C., Li, Z. et al., Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol. Cell Proteomics 2008, 7, 1639-1650.
12. He, Q. Y., Chen, J., Kung, H. F., Yuen, A. P., Chiu, J. F., Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 2004, 4, 271-278.
13. Baker, H., Patel, V., Molinolo, A. A., Shillitoe, E. J. et al., Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol. 2005, 41, 183-199.
14. Patel, V., Hood, B. L., Molinolo, A. A., Lee, N. H. et al., Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin. Cancer Res. 2008, 14, 1002-1014.
15. Chi, L. M., Lee, C. W., Chang, K. P., Hao, S. P. et al., Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol. Cell Proteomics 2009, 8, 1453-1474.
16. Peterson, G. L., A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 1977, 83, 346-356.
17. Meleth, S., Deshane, J., Kim, H., The case for well-conducted experiments to validate statistical protocols for 2D gels: different pre-processing=different lists of significant proteins. BMC Biotechnol. 2005, 5, 7.
18. Altman, D. G., Bland, J. M., Diagnostic tests 3: receiver operating characteristic plots. BMJ 1994, 309, 188.
19. Hanahan, D., Weinberg, R. A., The hallmarks of cancer. Cell 2000, 100, 57-70.
20. Garber, K., Energy deregulation: licensing tumors to grow. Science 2006, 312, 1158-1159.
21. Roesch-Ely, M., Nees, M., Karsai, S., Ruess, A. et al., Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 2007, 26, 54-64.
22. Liu, H., Peng, H. W., Cheng, Y. S., Yuan, H. S., Yang-Yen, H. F., Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol. Cell Biol. 2005, 25, 3117-3126.
23. Zhang, D., Li, F., Weidner, D., Mnjoyan, Z. H., Fujise, K., Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone. J. Biol. Chem. 2002, 277, 37430-37438.
24. Cans, C., Passer, B. J., Shalak, V., Nancy-Portebois, V. et al., Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc. Natl. Acad. Sci. USA 2003, 100, 13892-13897.
25. Tuynder, M., Susini, L., Prieur, S., Besse, S. et al., Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc. Natl. Acad. Sci. USA 2002, 99, 14976-14981.
26. Singh, S. K., Hasan, S. A., Sharma, S. C., Chandra, K., Ali, R., Serum lactate dehydrogenase in head and neck malignancy patients. Indian J. Physiol. Pharmacol. 1993, 37, 93-94.
27. Ralhan, R., Desouza, L. V., Matta, A., Chandra Tripathi, S. et al., Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol. Cell Proteomics 2008, 7, 1162-1173.
28. Lo Muzio, L., Leonardi, R., Mariggio, M. A., Mignogna, M. D. et al., HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma. Histol. Histopathol. 2004, 19, 119-128.
29. Gadewal, N. S., Zingde, S. M., Database and interactome map of genes involved in oral cancer. On-line J. Bioinform. 2007, 8, 41-44.
30. Porter, G. W., Khuri, F. R., Fu, H., Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin. Cancer Biol. 2006, 16, 193-202.
31. Hermeking, H., Benzinger, A., 14-3-3 proteins in cell cycle regulation. Semin. Cancer Biol. 2006, 16, 183-192.
32. Yoshida, K., Yamaguchi, T., Natsume, T., Kufe, D., Miki, Y., JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat. Cell Biol. 2005, 7, 278-285.
33. Samuel, T., Weber, H. O., Rauch, P., Verdoodt, B. et al., The G2/M regulator 14-3-3 sigma prevents apoptosis through sequestration of Bax. J. Biol. Chem. 2001, 276, 45201-45206.
34. Vaidya, M. M., Borges, A. M., Pradhan, S. A., Bhisey, A. N., Cytokeratin expression in squamous cell carcinomas of the tongue and alveolar mucosa. Eur. J. Cancer B Oral Oncol. 1996, 32B, 333-336.
35. Ku, N. O., Michie, S., Resurreccion, E. Z., Broome, R. L., Omary, M. B., Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc. Natl. Acad. Sci. USA 2002, 99, 4373-4378.
36. Santoro, M. M., Gaudino, G., Marchisio, P. C., The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration. Dev. Cell 2003, 5, 257-271.
37. Wang, S., Nath, N., Adlam, M., Chellappan, S., Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 1999, 18, 3501-3510.
38. Wang, S., Nath, N., Fusaro, G., Chellappan, S., Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol. Cell Biol. 1999, 19, 7447-7460.
39. Fusaro, G., Dasgupta, P., Rastogi, S., Joshi, B., Chellappan, S., Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 2003, 278, 47853-47861.
40. Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H. et al., Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000, 14, 34-44.
41. Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. et al., TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126, 107-120.
42. Bui, T., Thompson, C. B., Cancer's sweet tooth. Cancer Cell 2006, 9, 419-420.
43. Gatenby, R. A., Gillies, R. J., Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4, 891-899.
44. Brizel, D. M., Schroeder, T., Scher, R. L., Walenta, S. et al., Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51, 349-353.
45. Niemantsverdriet, M., Wagner, K., Visser, M., Backendorf, C., Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene 2008, 27, 1315-1319.
46. Matta, A., Bahadur, S., Duggal, R., Gupta, S. D., Ralhan, R., Over-expression of 14-3-3 zeta is an early event in oral cancer. BMC Cancer 2007, 7, 169.
47. Kim, J. W., Dang, C. V., Multifaceted roles of glycolytic enzymes. Trends Biochem. Sci. 2005, 30, 142-150.
48. Shukla, S., Govekar, R. B., Sirdeshmukh, R., Sundaram, C. S. et al., Tumor antigens eliciting autoantibody response in cancer of gingivo-buccal complex. Proteom. Clin. Appl. 2007, 1, 1592-1604.
49. Vashishta, A., Ohri, S. S., Proctor, M., Fusek, M., Vetvicka, V., Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells. Anticancer Res. 2006, 26, 4163-4170.
50. Vigneswaran, N., Zhao, W., Dassanayake, A., Muller, S. et al., Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum. Pathol. 2000, 31, 931-937.